Phoenix Gamma Follow-Up: How Comfortable Is The Funding Stack After The Early 2026 Refinancings
The January and February 2026 refinancings improved Phoenix Gamma's funding profile, but they did not remove the dependence on short funding. At year-end 2025 cash stood at only NIS 19.3 million, working capital was negative by NIS 379.3 million, and the comfort still rested mainly on rollover capacity, credit lines, and group support.
The Funding Stack Is Better, But The Comfort Still Comes From Access
The main article already argued that Phoenix Gamma's real 2026 test is not only credit growth, but whether that growth can be funded without losing flexibility. This follow-up isolates only that question: after the January and February 2026 refinancing actions, how comfortable is the funding stack really.
The short answer is yes, but only partly. Early 2026 improved the shape of the funding layer: NIS 350 million of bank loans were refinanced into 27 and 28 month facilities, the private commercial-paper balance was expanded to NIS 400 million, and Midroog kept the Aa2.il and P-1.il ratings in place. But this is still not comfort built on cash. It is comfort built on a machine that keeps working: card-voucher sales to banks, available signed lines, on-call facilities, access to the debt market, and group support.
That distinction matters because year-end 2025 did not close like a conservative balance sheet. Cash and cash equivalents fell to NIS 19.3 million, reported cash flow from operations was negative NIS 34.9 million, and working capital swung from a NIS 4.7 million surplus to a NIS 379.3 million deficit. At the same time, the short-funding line of commercial paper and short credit stood at NIS 837.5 million. Anyone looking only at the early 2026 refinancing thread could conclude that the pressure is gone. That would be the wrong read. It is more manageable. It is not gone.
Four points frame the whole picture:
- The early 2026 actions improved the source side, not the cash cushion. In January the company refinanced NIS 350 million of bank debt, and in February it increased the private CP balance to NIS 400 million.
- The comfort rests on source diversity, not cash on hand. Midroog describes wide funding channels, but part of that comfort depends on lines that are not fully committed and on maintaining coverage for the CP layer.
- Capital and covenants are far from tight. Minimum-capital equity stood at 10.4% against a 6% requirement, and the exposure-based capital ratio stood at 14.4% against a 4% requirement.
- The short layer is still too large to call the structure relaxed. Public Series 4 remained due on April 23, 2026, so even after the refinancing actions the immediate test did not disappear. It only became easier to carry.
What Actually Improved In Early 2026
The positive side of the funding picture is not cosmetic. It is real. On January 1, 2026 the company signed a refinancing with one of its bank lenders covering two loans totaling NIS 350 million. Each loan now carries annual interest in a range of prime minus 0.25% to prime minus 0.75%, with terms of 27 and 28 months. That is not new capital, but it does push one bank leg away from the immediate window.
A few weeks later, on January 27, Midroog assigned P-1.il to an expansion of private CP Series 2 of up to NIS 500 million par value. The logic matters more than the headline. The short-term rating was granted only after a 12-month sources-and-uses review and rests, among other things, on a signed commitment by the company to keep cash, excess vouchers and or available signed lines at at least 100% of the actual CP balance. On February 2 the company also used part of that capacity and increased the private CP balance from NIS 237.5 million at year-end 2025 to NIS 400 million.
That created a better-looking structure on the surface: private CP pushed out to January 2027, Bond D spread across 2028 to 2030, and a bank leg with a slightly more comfortable tenor.
That chart shows why 2026 did not start from zero. Already in 2025 the company had been extending part of the structure: average short-term funding rose 15.8% to NIS 1.198 billion, but average long-term funding jumped 59.7% to NIS 1.292 billion. Bond D, issued in June 2025, together with longer bank funding, had already improved the mix before the January and February events.
| Funding leg | What improved | What it still does not solve |
|---|---|---|
| Bank loans | NIS 350 million refinanced into 27 and 28 month facilities at prime minus 0.25% to prime minus 0.75% | This extends one leg, but it does not directly solve the public Series 4 maturity in April 2026 |
| Private CP Series 2 | Balance rose from NIS 237.5 million to NIS 400 million after February 2, 2026 | This is still short funding, and it still comes with a 60-day put option |
| Bond D | Principal only amortizes between 2028 and 2030, and the first coupon for the June 26, 2025 to January 10, 2026 period was calculated on a 5.40% annual rate | The bond improves tenor, but it does not by itself create a fresh liquidity cushion once the proceeds are already inside the system |
| Source diversity | Midroog describes bank lines, institutional loans, bonds, CP and group support sources | Part of the comfort still rests on ongoing market and bank access, not on free cash already sitting on the balance sheet |
Where The Comfort Is Real
To understand why the board and Midroog are not calling this a liquidity problem, the key is to separate cash pressure from capital and covenant pressure. On that side, the picture is actually comfortable.
Minimum-capital equity stood at 10.4% at year-end 2025 against a 6% requirement, leaving a 4.4-point surplus. In the guarantees activity the picture was even wider: the equity-to-exposure ratio stood at 14.4% against a 4% requirement, a 10.4-point surplus. The Bond D indenture is also nowhere near tight. Tangible equity is not supposed to fall below NIS 400 million and the equity-to-balance-sheet ratio is not supposed to fall below 7%, while equity at December 2025 stood at NIS 1.123 billion against a NIS 5.842 billion balance sheet.
That is the core paradox. Working capital deteriorated sharply, yet the regulatory capital ratio still remained well above the requirement. In other words, the structure is not comfortable because the balance sheet is naturally liquid or because the covenants are close to irrelevant. It is comfortable because the company still has institutional room to refinance, pledge, issue, and draw on a broad lender base.
There is also real infrastructure at the line level. At year-end 2025 the company had two unused signed bank facilities, NIS 200 million and NIS 100 million, expiring in December 2026 and April 2026 respectively. Midroog added that, in its review as of September 30, 2025, the company also relied on significant uncommitted on-call bank lines, a roughly NIS 306 million credit line from Phoenix Insurance, and a roughly NIS 200 million guarantee from Phoenix Finance.
So the comfort is real. It just needs to be read correctly. It is comfort based on funding access and refinancing capacity, not on idle cash.
Where The Structure Is Still Tight
The other side of the story sits in two places: the actual cash-flow picture, and the weight that remained in the short bucket even after the refinancing actions.
The board itself presents two different cash frames, and they should not be mixed. On the reported basis, 2025 cash flow from operations was negative NIS 34.9 million, mainly because of credit-book growth. After negative investing cash flow of NIS 26.6 million and positive financing cash flow of NIS 29.7 million, cash fell by NIS 31.9 million to only NIS 19.3 million.
At the same time, the company also presents a more normalized operating frame for its lending activity: if long-term loan proceeds and net bond issuance are added back, normalized operating cash flow comes out at NIS 105.9 million.
That gap is not technical. It is the whole point. Under a normalized frame, the business can generate cash. Under the all-in frame, flexibility still depends on refinancing and the funding market. That is why the NIS 105.9 million cannot be treated as a cash cushion. It is not. Actual year-end cash was only NIS 19.3 million.
This is where the short layer comes back into focus. At December 31, 2025 the line of commercial paper and short credit stood at NIS 837.5 million. Within that same year-end picture, the private CP balance stood at NIS 237.5 million, and public Series 4 had been issued in NIS 600 million par value with a bullet maturity on April 23, 2026. So even after the February private-CP expansion, the immediate test remained public and near-dated.
The subtler point is that the P-1.il rating does not create free flexibility. It comes with a constraint. Midroog states explicitly that the short-term rating rests on a commitment by the company to hold cash, excess vouchers and or available signed lines at at least 100% of the actual CP balance. That is supportive, but it also means part of the gross flexibility is already earmarked in advance for the CP layer.
There is also a forward warning, and it matters. Midroog wrote that the entry into consumer credit, together with continued growth in construction finance and real-estate-collateral lending, is expected to lengthen portfolio duration and may constrain financial and underwriting flexibility. That point is material because those are exactly the segments where the company is growing. The early 2026 refinancings improve the source side, but the activity mix itself is pulling in the opposite direction.
What Has To Happen For The Structure To Look Truly Comfortable
If Phoenix Gamma's funding stack is to look truly comfortable, and not merely manageable, three things need to happen in the next reports.
First: the public short layer needs to roll without using up too much of the backup layer. As long as Series 4 is still sitting against April 2026, the key question is not whether market access exists, but how expensive it is and how much flexibility remains after it.
Second: reported cash needs to stop looking immaterial relative to the scale of the platform. Even if the business model is built on card vouchers and daily rollover, NIS 19.3 million of cash at the end of a year with a NIS 5.8 billion balance sheet forces the whole structure to be read through funding access rather than through natural liquidity.
Third: the growth in longer-duration segments needs to stop eroding the advantage of the voucher business. Up to now, Gamma's flexibility has come largely from the fact that its core activity is very short-duration, relatively liquid, and saleable to banks. If a growing share of the book sits in consumer credit, construction finance, and real-estate-backed lending, it is not safe to assume that the historical level of flexibility will remain unchanged.
Bottom Line
Phoenix Gamma's funding stack after the early 2026 refinancing actions is better, but still not truly relaxed. The company has shown that it can access banks, private CP, public bonds, and group support sources. That is a real strength, and at year-end 2025 both capital and covenants were comfortably away from pressure.
But the practical bottleneck remains the same: the comfort still depends on the rollover engine staying open. It does not depend on a large cash balance, and it certainly does not depend on positive working capital. Year-end 2025 closed with a NIS 379.3 million working-capital deficit, NIS 19.3 million of cash, and negative reported operating cash flow. This structure can be maintained, but only as long as all the channels keep functioning.
That is the real conclusion of the follow-up: the early 2026 refinancings bought time and widened the options, but they did not yet turn Phoenix Gamma's funding layer into a conservative one. If the next reports show that the public CP layer also rolls smoothly, that reported cash recovers, and that the longer book does not erode flexibility, the read can improve quickly. If not, 2026 will remain a funding-structure test, not just an earnings test.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.